Thank you, Mr. Chair. So two issues there. One is the chemotherapy drugs specifically which is what this particular item is in relation to. The services here, obviously costs are going up, drug costs are going up. There are some recoveries and some rebates as a result of agreements that are being signed in terms of providing the ability to seek some lower cost drugs, but we do have a shortage at $484,000. There's more clients requiring the drugs and then also the fact that the drugs are more costly.

Mr. Chair, more broadly, with drug-related costs and expenditures, certainly, again, I would probably defer that to Minister of Health and Social Services, but I know there is a fair bit of effort in the space to sign further and other agreements that can help lead to reduce costs on drugs, again, broadly across the board. Thank you.